Pharmacokinetics of Leritrelvir(Ray1216) in Elder Participants

Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011

NCT02431481 ·Status: COMPLETED ·Phase: PHASE1

The Effect of Severe Kidney Impairment on Cenerimod Pharmacokinetics

NCT05004311 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Clinical Probes and Characteristics of Endogenous Biomarker in Chinese Older Adults

NCT05893849 ·Status: UNKNOWN

A Pharmacokinetic Study of Lanifibranor in Healthy Adult Chinese Subjects

NCT06126562 ·Status: COMPLETED ·Phase: PHASE1

Hepatic Impairment and Renal Impairment Study of SIM0417 Combined With Ritonavir

NCT05731804 ·Status: UNKNOWN ·Phase: PHASE1

A Study on the Effect of Renal Impairment on the Pharmacokinetics of RO4917838

NCT01510899 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Amcenestrant in Female Hepatic Impaired Participants as Compared to Participants With Normal Hepatic Function

NCT05126329 ·Status: TERMINATED ·Phase: PHASE1

Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment

NCT03289208 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, and Pharmacokinetic of Single Dose of Pitavastatin 4 mg in Severe Renal Patients Versus Healthy Adult Volunteers

NCT01043094 ·Status: COMPLETED ·Phase: PHASE4

A Pharmacokinetic Study of TAK-438 in Healthy Adult Chinese Participants

NCT03085836 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Orelabrutinib Tablets in Subjects With Hepatic Impairment and Healthy Subject

NCT05684653 ·Status: UNKNOWN ·Phase: PHASE1

Pharmacokinetics of Sotorasib in Healthy Participants and Participants With Moderate or Severe Hepatic Impairment

NCT04887064 ·Status: COMPLETED ·Phase: PHASE1

Study of Bioavailability, Pharmacodynamics and Safety of SHR-1209 Administered by Single Subcutaneous Injection at Different Sites in Healthy Volunteers

NCT05370950 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of ZSP1273 in Participants With Hepatic Impairment

NCT05856513 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics, Pharmacodynamics and Safety of SHR4640 in Patients With Hepatic Impairment

NCT04305392 ·Status: UNKNOWN ·Phase: PHASE1

Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Patients With Hepatic Impairment

NCT03160014 ·Status: UNKNOWN ·Phase: PHASE1

Pharmacokinetics of LCQ908 in Patients With Renal Impairment

NCT01558323 ·Status: COMPLETED ·Phase: PHASE1

Relative Bioavailability Study of SHR3680

NCT04903158 ·Status: UNKNOWN ·Phase: PHASE1

A Single- and Multiple-Dose Study of the Pharmacokinetics of TAK-491 in Healthy Chinese Participants

NCT02541669 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacokinetic and Safety Study of E7080 in Subjects With Mild (10 mg), Moderate (10 mg), and Severe Hepatic Impairment (5 mg) and Normal Hepatic Function (10 mg)

NCT02421042 ·Status: COMPLETED ·Phase: PHASE1

A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection

NCT05865574 ·Status: UNKNOWN ·Phase: PHASE1

KD025 Hepatic Impairment Study With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment

NCT04166942 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacokinetics (PK) and Safety Study of Oral Fampridine-PR 10 mg in Chinese, Japanese, and Caucasian Adult Healthy Volunteers

NCT01215084 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Hepatic Impairment

NCT04859426 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating The PK And Safety Of Neratinib In Healthy Subjects And Subjects With Chronic Liver Disease

NCT00781430 ·Status: COMPLETED ·Phase: PHASE1